Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences RFK Jr. & claimed regenerative peptides like BPC 157 The Niche OncLive's FDA Approval Report: The Regulatory Rundown for March 2025 OncLive FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York